Top Authors

• Most frequent coverage on ACOR

• 
  Mike Havrilla (1926 followers)

  • Positive FDA Panel Outcome for Acorda Therapeutics (Thu, Oct 15)
  • FDA Calendar Updates: Acorda, Amgen (Tue, Aug 4)
  • FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences (Thu, Jul 2)

  More by Mike Havrilla on ACOR »
• 
  Lon Juricic (18 followers)

  • Icahn's Hedge Fund Has New Stakes In Genzyme and Childrens Place, Among Others (Thu, Nov 15)
  • Loeb's Third Point Issues Latest 13F: Summary of Holdings (Thu, Aug 16)
  • Loeb's Third Point LLC Lowering Its Stake in Acorda (Fri, May 25)

  More by Lon Juricic on ACOR »
• 
  Zacks.com (1057 followers)

  • Bullish on Acorda: New Drug Looks Promising (Tue, Jun 23)
  • Acorda Pops on Good News (Thu, May 7)
  • Acorda Down on FDA Delay (Tue, Mar 31)

  More by Zacks.com on ACOR »

• Most followed authors on ACOR

• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Wed, Feb 25)

  More by SA Editor Rachael Granby on ACOR »
• 
  Market Folly (2001 followers)

  • SAC Capital Portfolio Update: 37 13G Filings (Thu, Jan 15)

  More by Market Folly on ACOR »
• 
  Mike Havrilla (1926 followers)

  • Positive FDA Panel Outcome for Acorda Therapeutics (Thu, Oct 15)
  • FDA Calendar Updates: Acorda, Amgen (Tue, Aug 4)
  • FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences (Thu, Jul 2)

  More by Mike Havrilla on ACOR »

• Newest authors on ACOR

• 
  Justin M. Hall (672 followers)

  • On Small Cap Drug Makers and Volatility (Sun, Oct 18)

  More by Justin M. Hall on ACOR »
• 
  M. E. Garza (520 followers)

  • A Mixed Bag for Traders and Investors in Healthcare (Mon, Oct 12)
  • Stage Set for Acorda Bounce? (Sun, Oct 11)

  More by M. E. Garza on ACOR »
• 
  The Burrill Report (199 followers)

  • Dealmaking Sweeps the Biotech Sector (Sun, Jul 5)

  More by The Burrill Report on ACOR »

• Most commented on ACOR

• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Wed, Feb 25)

  More by SA Editor Rachael Granby on ACOR »
• 
  Mike Havrilla (1926 followers)

  • Positive FDA Panel Outcome for Acorda Therapeutics (Thu, Oct 15)
  • FDA Calendar Updates: Acorda, Amgen (Tue, Aug 4)
  • FDA Calendar Updates: Repros, Discovery, Acorda, Human Genome Sciences (Thu, Jul 2)

  More by Mike Havrilla on ACOR »
• 
  Dr. Anthony (4 followers)

  • Why I Doubt the FDA Will Approve Acorda's Fampridine (Fri, Apr 24)

  More by Dr. Anthony on ACOR »